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Evaluation of Free and Total L-ThyrOxifle in Serum by a Commercial
Procedure
M.J. Obregon,” A. Kurtz,2 R. Ekins,2 and G. Morreale de Escobar1
We assessed a commercial kit (Corning Medical) for “free”
and total thyroxine determination, results being compared
to those obtainedby the Ekins and Ellis dialysis method
(freethyroxine)andthemethod of Weeke and #{248}rskov(total
thyroxine). The kit procedure permits determination of both
freeand totalthyroxinewithin4 to 5 h, and the combined
results may disclose changes in binding to plasma proteins
that would be missed if only free thyroxine were deter-
mined.
With both free-thyroxine methods, the values distin-
guished hyperthyroid patients from normal controls and
pregnant women with 100% accuracy, but there was
some overlap between hypothyroid patients and controls.
Absolute values with the kit procedure often exceed those
obtained by dialysis, especially for hypothyroid patients
and pregnant women. We conclude that the kit may be of
as much diagnostic value as the dialysis method if the
limitations regarding absolute values are kept in mind and
the test is not used as a substitute for thyrotropin deter-
minations in cases of suspected hypothyroidism.
Additional Keyphrases: “kit” methods thyroid status
Circulating thyroxine and triiodothyronine are mostly
bound to plasma proteins, and it is generally admitted that
the unbound (“free”) fractions are more directly related to the
metabolic state than is either the total or bound fraction (I,
2). Corning Medical, Medfield, MA 02052, has developed a
method for determination of “free” thyroxine (F-T4) as a re-
sult of studies on the kinetics and thermodynamics of the
binding of thyroxine to anti-T4 antibodies immobilized on
glass particles (3). These studies demonstrated that the rate
at which thyroxine adsorbs onto the immobilized antibody is
related to the amount of F-T4, the process being monitored
with labeled thyroxine. The most adequate response “me-
tameters” for the calculation of F-T4 from the raw data ob-
tained with the reagents supplied by Corning Medical have
been discussed by Ekins (4) and have been taken into account
by the manufacturers.
Here, we report an evaluation of the F-T4 kit supplied by
Corning Medical. We determined that F-T4 and total thy-
roxine (T-T4) with the kit and compared results with those
obtained by other methods: a dialysis method for F-T4 (5) and
a highly sensitive radioimmunoassay for T-T4 (6).
Materials and Methods
We used a total of 85 samples. None of the 20 healthy vol-
unteers were taking oral contraceptives or had any clinical
history of thyroid disease. Twenty samples were obtained from
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patients who were clinically thyrotoxic and had high serum
triiodothyronine concentrations, 25 from patients who where
clinically hypothyroid and had higher than normal circulating
thyrotropin concentrations, and 20 from pregnant women.
The samples were collected at the Middlesex Hospital,
London. Aliquots were used there to determine F-T4 by the
dialysis procedure (5). T-T and F-T4 were determined in
Madrid with the kit reagents provided by Corning Medical,
and T-T4 and total triiodothyronine (T-T;t) by previously
validated methods (6, 7). The code for identification of the
samples was broken after we received the data for the F-T4
determinations carried out at the Middlesex Hospital. The
only plasma thyrotropin determinations were those done to
confirm previous thyrotropin determinations used for initial
diagnosis, and these were done after breaking the code.
In determining T-T4 and F-T4 concentrations by the kit
procedure we used four of these kits for the 85 sera, the un-
known samples being allotted at random to each kit. Some of
the samples, also chosen at random, were run in several as-
says.
Briefly, the assay requires 25-zL aliquots of standards of
unknowns, pipetted in quadruplicate; two tubes receive a
solution containing ‘251-labeled thyroxine (the A series of
tubes) and two the same solution except containing thimerosal
as blocker of thyroxine binding to proteins (B series of tubes).
After a 30-mm incubation, the anti-thyroxine antibody, im-
mobilized on glass particles, is added. After 30 mm, the tubes
are centrifuged and the supernates discarded. The radioac-
tivity of the A and B series of tubes (cpm A; cpm B) and of the
total radioactivity added (cpmT) is determined by 1-mm
counts in an automatic gamma counter.
The cpm B values for the standards are used to plot the
T-T4 standard curve, with use of data supplied by the man-
ufacturers (13, 52, 107, 210, and 315 nmol/L). The T-T4 value
and the cpm A values of the standards are used to calculate
the response “metameter” Y IY = (cpmA/cpmB) X T-T4,
which is plotted against the F-T4 concentrations supplied by
the manufacturers (6.4, 12.8, 25.7, 51.5, and 77.2 pmol/L) to
obtain the F-T4 standard curve.
F-T4 was also determined by the dialysis procedure de-
scribed by Ekins and Ellis (5). In brief, 200-L aliquots of sera
are dialyzed overnight at 4 #{176}Cagainst 5 mL of dialysismedium
containing sodium azide (not thimerosal) as hacteriostat. The
thyroxine in the dialysate is then determined by radioim-
munoassay.
T-T4 and T-T3 were also determined according to Weeke
and Orskov (6, 7), with minor modifications introduced by
Obregon (8), such as the use of polyethylene glycol instead of
wick chromatography to separate free and antibody-bound
labeled thyroxine. The very high specific activity of the labeled
thyroxine and triiodothyronineobtained inthe laboratory(9,
10) allows the use of very small serum aliquots, namely 0.5 zL
per tube and 10 tL per tube for T-T4 and T-T:t, respectively.
The radioimmunoassay buffer contains 0.6 mmol of thi-
merosal, addition of other “blockers” being necessary for
T-T4. For T-T:4,2.37nmol of8-anilino-1-naphthalenesulfonic
acid isadded as “blocker.”
We used the kit from Corning Medical to determine serum
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Table 1. Between-Assay Variation in F-T4 and T-T4 Values by the Kit Procedure for Two Control Sera
(C1 and C2, Supplied by the Manufacturer) and Six Unselected Sera
Hyperthyroid
Hyperthyroid
Hypothyroid 3
Hypothyroid
Pregnant 2
Pregnant
Free thyroxine Total thyroxine
Mean SDSD
a Numberof kits in which the sample was assayed in duplicate.
b Data supplied by the manufacturer for free thyroxine inC1 andC2 are 17.4 (SD 3.2) and 38.0 (SD 5.8) pmol/L. respectively: for total thyroxine 76 (SD 9) and
148 (SD 14) nmol/L. respectively.
Table 2. Mean Values (and SD) for Total and Free Thyroxine in Sera from Indicated Types of Subjects
by the Kit Procedure (Method A) and the Method of Weeke and Orskov (Method B for T-T4) or the
Dialysis Procedure of Ekins and Ellis (Method B for F-T4), and the Mean Values of the
Individual Ratios (Method A/Method B)
a p for paired t-test.
#{176}Six of 25 samples hada T-T4 value <13 nmol/L by MethodB. For the present calculations they have beenassigneda value of 13 nmol/L.
C One of 20 samples hada T-T4 value >322 by Method A andwas assigned this value for the calculations.
d Three of 25 samples hadF-T4 value <6.4 pmol/L by Method A and was assigned this value for the calculations.
#{176}Five of 20 samples had F-T4 values at the upper limit of detection by method A and were assigned a value of 77.2 pmol/L for calculations.
thyrotropin, following the supplier’s instructions without
modification.
Results
Using the reagents provided by Corning Medical, we found
the radioactivities in duplicate tubes to be almost identical.
The standard curves for F-T4 obtained with the fourdifferent
kitswere almost superimposable. There was a somewhat larger
variation in the T-T4 standard curves in the range corre-
sponding to low T-T4 (52 nmol/L, and lower). Table 1 sum-
marizes between-assay variations we obtained for the two
control sera supplied, as well as for six unknown sera chosen
at random. The CVs are quite satisfactory for the F-T4 and
T-T4 values of the sera tested with the four kits, the two
samples from hypothyroid patients excepted.1
Figure 1 shows results for T-T4 by both the kit method and
the comparison method. Table 2 shows the mean values (and
SD) for the different groups of patients and the means of the
individual ratios between the values obtained with the two
different methods. Nineteen of 20 sera from normal volunteers
had aT4 concentration between 77 and 154 nmol/L. All of the
20 samples from hyperthyroid patients had a T-T4 concen-
tration exceeding 180 nmol/L by both methods, several sam-
.1This may he owing to differences in the T-T4 standard curves in
the low T-T4 range; when we used cpm B/cpm T data obtained for
each of the two hypothyroid sera on different occasions, the be-
tween-assay CVs were reduced to 1.8 and 2.9%.
pleshaving a T-T4 near orabove the upper limitofdetection
of the kit method. About 70% of the 20 sera from pregnant
women had a T-T4 value exceeding 154 nmol/L with the kit
method, whereas with the reference method only 40% ex-
ceeded the normal range.
The major difference between the results obtained by the
two methods was for sera from hypothyroid patients. None
of them had a T-T4 value above 77 nmol/L by the reference
method, but with the kit procedure there was some degree of
overlap with the normal range, four of 25 samples giving a
T-T4 value above 77 nmol/L, though two of them did not ex-
ceed 90 nmol/L. Although in all groups except the hyperthy-
roid group the T4 value obtained with the kit procedure ex-
ceeded that with the reference method (Table 2), the differ-
ence was particularly striking in the case of sera from hypo-
thyroid patients.
These relationships are also illustrated in Figure 2, where
the individual T-T4 values obtained with both methods are
plotted.
Figure 3 shows the results for F-T4 by the kit and the dial-
ysis methods. The reported reference interval differs for the
two methods: 14.2-32.2 and 8.5-23.0 pmol/L, respectively. The
F-T4 values found for all 20 control sera and 25 sera from
hyperthyroid patients fell, respectively, within and above the
normal ranges. The F-T4 values for sera from pregnant women
all fell within the reported normal range with the kit method.
With the dialysis procedure, one of the 20 sera from pregnant
women showed a value below the normal range. With both
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Fig. 1. Total thyroxine (T4)concentrations in sera from 20 normal
controls, 20 pregnant women, 20 hyperthyroid, and 25 hypo-
thyroid patients, as determined by the kit procedure (Method A)
and by the method of Weeke and Orskov (Method B, ref. 6)
In this and other figures, the shaded areas represent normal ranges and dotted
lines the upper or lower limits of detection with usual sample volumes.
methods, most F-T4 values for sera from hypothyroid patients
fell below the normal range, but there was some overlap with
the normal range and with values found for the control sera.
This was the case for four sera with use of the kit procedure,
one of them having a borderline value, and for six sera by the
dialysis method. Three sera giving a F-T4 value within the
normal range with the kit reagents were the same ones that
also had a normal T-T4 and a normal F-T4 by the dialysis
method.
The data obtained with the Corning Medical procedure
were higher than those by the dialysis method for all groups
except the hyperthyroid one (Table 2). The highest ratios were
found for the sera from hypothyroid patients and pregnant
women.
Figure 4 shows T-T:t values we obtained with the method
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Fig. 3. Free thyroxine concentrations of the same sera as for
Figure 1, as determined by the Corning Medical procedure
(Method A) and by the dialysis method (Method B, ref. 5)
of Weeke and #{216}rskov(7), which support the stated diagnosis
of the patients. So did the concentrations of thyrotropin in the
plasma of the 17 pregnant women tested and of the 25 sera
from hypothyroid patients.4
Discussion
The laboratory performance of the kit was quite satisfac-
tory. The procedure is simple, and both the T-T4 and F-T4 of
a patient are known within 4-5 h. Both values are obtained
in a single test, with corresponding simplification of laboratory
routine. The combined results for F-T4 and T-T4 disclose the
presence of changes in binding to plasma proteins, which
would be missed on the basis of the F-T4 data alone.
The standard curves for F-T4 and T-T4 obtained with dif-
ferent kits were very similar, except for T-T4 in the low range.
This might be due to excessive spacing of the low T-T4 stan-
dards.5 Results obtained with the internalcontrolserasup-
plied by the manufacturers fell within the reported means ±
1 SD. Between-assay CVs were satisfactory for sera from
normal and hyperthyroid patients, and pregnant women. CVs
for the F-T4 of the two sera from hypothyroid patients could
not be calculated and those for the T-T4 were higher(-.‘20%),
With data on both F-T4 and T-T4, hyperthyroid patients
can be identifiedand distinguishedwith 100% accuracy from
normal people and pregnant women, both with the kit and the
other methods we used. Diagnostic accuracy of the F-i’4 values
was less for the group of 25 hypothyroid patients, both with
the kit procedure (84%) and the dialysis method (76%), as
already observed by others (11). Thus, from the present series
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Fig. 2. Total thyroxine concentrations, corresponding to the
same samples as for Figure 1: Values obtained by the Medical
Corning procedure (Method A) are plotted against those obtained
by the method of Weeke and Orskov (Method B)
._1
The lowest plasma thyrotropin value in the hypothyroid group
(16 punits/mL), although well above the normal range given by the
manufacturers (O.2-.9.1punits/mL), corresponded to a patient with
T-T4 (kit procedure) and F-i’4 (both the kit and the dialysis methods)
values well within the normal range.
r The manufacturers are aware of this problem and are taking
measures to increase the number of standards in the low Ti’
range.
METHOD A METHOD B METHOD A METHOD B
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Fig. 4. Total triiodothyronine concentrations of the same sera
as for Figure 1, as measured with the method of Weeke and
#{248}rskov(7)
ofpatients,itwould appear thatthe kitmethod gives at least
the same clinicalinformation as that obtained by a well-es-
tablished dialysis technique, but is simpler to perform, not
requiring any more experience than is needed for other routine
radioimmunoassays.
However, the diagnostic performance of the T-T4 and T-T:t
data, as obtained by the methods of Weeke and Orskov (6, 7)
was 100%, even in the hypothyroid range. One of the normal
controls might have been classified as hypothyroid, on the
basis of the T-T4 value alone, but this diagnosis would have
been excluded after determination of thyrotropin, which was
normal. However, none of the hypothyroid patients would
have been missed on the basis of the T-T4 or T-T:t data
alone.
The absolute values obtained for F-T4 and for T-T4 con-
centrations depend on the method used; this is especially
evident for sera from hypothyroid patients and pregnant
women. Itis impossible at present to know which procedures,
if any, give “true” results, i.e., results that represent the actual
circulating F-T4 and T-T4 concentrations. As pointed out (4),
none of the dialysis methods for F-T4 can be considered as
having the status of a reference technique. A possible factor
that might increase the F-T4 results in the case of the kit
procedure and other procedures in which the patient’s plasma
proteins are present during the radioimmunoassay, is non-
specific binding of the labeled thyroxine tracer, which would
be more prominent in sera with low F-T4 and a larger pro-
portion of unoccupied binding sites (as in hypothyroidism)
or in the sera with high thyroxine-binding globulin (as in
pregnancy). Such a factor might also contribute to overesti-
mation of the T-T4 in these groups, despite addition of a
standard amount of thimerosal. An overestimation of the T-T4
might further influence the F-T4 value, because the T4 value
is used for calculation of the response “metameter” Y. The
dialysis procedure (5) would be free from such a potential
source of error in the case of the F-T4 determinations. The
method of Weeke and Orskov (6), because a very small serum
sample is required, 0.5 tL, would minimize it in the case of
T-T4.
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